Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Centessa Pharmaceuticals Plc ADR (NQ: CNTA ) 15.89 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Centessa Pharmaceuticals Plc ADR < Previous 1 2 3 4 5 Next > SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Centessa Pharmaceuticals plc with Losses of $100,000 to Contact the Firm September 30, 2022 From The Schall Law Firm Via Business Wire CENTESSA ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Centessa Pharmaceuticals Plc and Encourages Investors to Contact the Firm September 29, 2022 From Bragar Eagel & Squire, P.C. Via Business Wire INVESTOR ALERT: Centessa Pharmaceuticals plc Investors with Substantial Losses Have Opportunity to Lead the Centessa Class Action Lawsuit - CNTA September 29, 2022 From Robbins Geller Rudman & Dowd LLP Via Business Wire Analyst Ratings for Centessa Pharmaceuticals August 11, 2022 Within the last quarter, Centessa Pharmaceuticals (NASDAQ:CNTA) has observed the following analyst ratings: Via Benzinga Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Centessa Pharmaceuticals plc (CNTA) September 29, 2022 From Robbins LLP Via Business Wire SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Centessa Pharmaceuticals plc with Losses of $100,000 to Contact the Firm September 29, 2022 From The Schall Law Firm Via Business Wire Important Biotech Catalysts For September 14, 2022 - End Of The Day Summary September 14, 2022 Via Benzinga Centessa Culls Early-Stage Asset For Inherited Disorder August 10, 2022 Via Benzinga BMO Capital Sees Almost 300% Upside On Centessa Stock June 17, 2022 Via Benzinga FDA Grants Orphan Drug Status To Centessa's Hemophilia B Candidate September 14, 2022 Centessa Pharmaceuticals (NASDAQ: CNTA) announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to SerpinPC for the treatment of hemophilia B. A Phase 2a... Via Benzinga Centessa Pharmaceuticals Plc (NASDAQ:CNTA) Shareholder Notice: Investigation over Potential Securities Laws Violations August 23, 2022 San Diego, CA -- (SBWIRE) -- 08/23/2022 -- Centessa Pharmaceuticals plc is under investigation concerning possible securities laws violations in connection with certain financial statements. Via SBWire INVESTIGATION NOTICE: The Schall Law Firm Encourages Investors in Centessa Pharmaceuticals plc with Losses of $100,000 to Contact the Firm August 15, 2022 From The Schall Law Firm Via Business Wire INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Centessa Pharmaceuticals plc with Losses of $100,000 to Contact the Firm August 12, 2022 From The Schall Law Firm Via Business Wire Morgan Stanley Downgrades Centessa Pharmaceuticals: Here's What You Need To Know August 12, 2022 Morgan Stanley downgraded its rating of Centessa Pharmaceuticals (NASDAQ:CNTA) to Underweight with a price target of $5.00, changing its price target from $10.00 to $5.00. Shares of Centessa... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2022 August 12, 2022 Via Benzinga EQUITY ALERT: Rosen Law Firm Encourages Centessa Pharmaceuticals plc Investors with Losses in Excess of $100K to Inquire About Class Action Investigation – CNTA August 12, 2022 From The Rosen Law Firm, P.A. Via Business Wire Goldman Sachs Maintains Neutral Rating for Centessa Pharmaceuticals: Here's What You Need To Know August 11, 2022 Goldman Sachs has decided to maintain its Neutral rating of Centessa Pharmaceuticals (NASDAQ:CNTA) and lower its price target from $5.00 to $4.00. Shares of Centessa Pharmaceuticals are trading down... Via Benzinga Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial August 10, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Centessa Pharmaceuticals: Q2 Earnings Insights August 10, 2022 Centessa Pharmaceuticals (NASDAQ:CNTA) reported its Q2 earnings results on Wednesday, August 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session June 02, 2022 Via Benzinga 89 Biggest Movers From Friday June 21, 2022 Gainers Revlon, Inc. (NYSE: REV) jumped 91.3% to close at $3.73 on Friday after the company filed for Chapter 11 bankruptcy. Via Benzinga Stocks That Hit 52-Week Lows On Friday June 03, 2022 During Friday's trading, 69 companies set new 52-week lows. Via Benzinga The Daily Biotech Pulse: Mesoblast, Novartis Sever COVID-19 Treatment Partnerships, Sigilon To Reduce Workforce, ASH Presentations Move Stocks December 14, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Vaccitech To Buy Avidea For $40M Vaccitech plc (NASDAQ: VACC) announced that... Via Benzinga 74 Biggest Movers From Yesterday June 03, 2022 Gainers Via Benzinga 2 Big Stock Bets That Are Insiders Are Buying Now December 06, 2021 Reddit users picked their favorite biotech stocks, and all of them have fallen this year. The insiders have a different buying strategy. Via InvestorPlace Stocks That Hit 52-Week Lows On Thursday June 02, 2022 During the Thursday's session, 100 stocks hit new 52-week lows. Via Benzinga Why Did Centessa's Shares Plunge 10% Today? November 01, 2021 Centessa Pharmaceuticals plc (NASDAQ: CNTA) announced proof-of-mechanism data from the first three subjects in Phase 1 Part B study of ZF874 in Alpha-1 Antitrypsin... Via Benzinga 53 Stocks Moving In Thursday's Mid-Day Session June 02, 2022 Gainers Via Benzinga Stocks That Hit 52-Week Lows On Wednesday January 05, 2022 Before 10 am on Wednesday, 99 companies set new 52-week lows. Facts of Interest About Today's 52-Week Lows: Sea (NYSE:SE) was the largest firm by market cap to set a... Via Benzinga 64 Biggest Movers From Yesterday November 02, 2021 Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) shares climbed 137.4% to close at $6.03 on Monday on abnormally-high volume. The stock is seeing increased interest by traders on... Via Benzinga < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
